+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Exoskeleton Market by Product Type, Application, End-User, Material Type - Global Forecast to 2030

  • PDF Icon

    Report

  • 194 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5012949
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Exoskeleton Market grew from USD 999.81 million in 2024 to USD 1.19 billion in 2025. It is expected to continue growing at a CAGR of 18.70%, reaching USD 2.79 billion by 2030.

Charting the Rise of Exoskeleton Innovation

The exoskeleton market stands at a pivotal juncture where cutting-edge technology converges with an expanding array of applications across healthcare, industrial, and defense sectors. Innovations in materials, sensor integration, and power systems have propelled these wearable devices from experimental prototypes into commercially viable solutions that enhance human performance, alleviate physical strain, and redefine rehabilitation and mobility assistance. This report opens with a concise exploration of how exoskeletons have evolved from conceptual demonstrations to practical implementations, mapping the technological milestones that have catalyzed broader adoption.

By framing the narrative in the context of rising global demand for ergonomic support and productivity enhancements, we set the stage for a deeper examination of market drivers, regulatory influences, and competitive dynamics. The introduction also highlights the demographic and industrial trends fueling uptake, from an aging population in developed nations to labor-intensive manufacturing growth in emerging economies. Through this lens, readers will gain clarity on the strategic imperatives shaping vendor roadmaps and investment priorities.

Uncovering Transformative Shifts Shaping the Exoskeleton Market

Recent years have witnessed a rapid convergence of several transformative forces reshaping the exoskeleton landscape. Advances in lightweight composites and modular design paradigms have significantly reduced device weight while enhancing customization options. Concurrently, progress in battery energy density and embedded electronics has extended operational endurance, enabling applications that require continuous assistance over extended work shifts or rehabilitation sessions. These technological breakthroughs are synchronizing with the proliferation of digital health platforms, creating new synergies between physical support devices and data-driven therapy protocols.

On the regulatory front, harmonized standards emerging across Europe and North America have streamlined certification pathways, accelerating product launches while ensuring rigorous safety and efficacy benchmarks. Moreover, the integration of artificial intelligence and machine learning algorithms has unlocked predictive control functionalities, allowing exoskeletons to adapt in real time to user biomechanics and environmental conditions. Together, these shifts underscore a market in transition, moving from niche use cases toward scalable solutions with broad commercial and clinical relevance.

Assessing the Cumulative Impact of 2025 United States Tariffs on Exoskeleton Trade

The introduction of new tariffs by the United States in 2025 has created a complex trade environment for exoskeleton manufacturers and suppliers. Components sourced from key exporting regions now face elevated duties, prompting companies to reassess global value chains and supplier contracts. As a result, many vendors have initiated dual-sourcing strategies, splitting orders between domestic and alternative low-tariff jurisdictions to mitigate cost pressures. This reactive approach, however, increases operational complexity and can extend lead times for critical parts.

Simultaneously, end-users in sectors such as automotive assembly and construction are weighing the total cost of ownership more rigorously, factoring in potential tariff-related price adjustments into their procurement decisions. In response, several manufacturers have announced plans to establish assembly or subassembly lines within the United States to qualify for tariff exemptions. The cumulative effect of these measures is a gradual realignment of manufacturing footprints and a reset of supply chain assumptions-trends that will continue to shape competitive positioning and margin structures throughout the forecast horizon.

Deep Dive into Product Application and User Driven Segmentation Dynamics

The exoskeleton market’s heterogeneous nature demands a nuanced segmentation framework to capture diverse customer needs and technology pathways. Based on product type, the market is analyzed across full body exoskeletons, lower body exoskeletons, and upper body exoskeletons. Full body systems encompass distinct healthcare applications for patient support and specialized military applications for enhanced soldier endurance. Lower body categories branch into non-powered variants, targeting fitness and rehabilitation settings as well as orthopedic uses, while powered lower body exoskeletons focus on assistive devices for mobility impairment and robust industrial applications in manufacturing. Upper body solutions further divide into chest support modules designed to alleviate spinal load, medical enhancement rigs for patient therapy, and shoulder support assemblies optimized for repetitive motion tasks.

When viewed through the lens of application, accessibility aids form a dedicated submarket that integrates mobility assistance with structured physical therapy programs. The healthcare domain extends from elderly assistance platforms and rehabilitation therapy suites to advanced surgical assistance exoskeletons that deliver unprecedented precision. Industrial deployments highlight automotive manufacturing integrations, construction assistance frameworks, and logistics and warehousing innovations aimed at reducing musculoskeletal injuries. The military and defense segment spans combat readiness systems, heavy load carriage exoskeletons, and pilot assistance gear engineered for extended flight operations.

End-user analysis reveals corporate adoption driven by workplace ergonomics initiatives and corporate wellness programs, while the consumer segment embraces home care exoskeletons and personal fitness enhancement devices. Hospitals and clinics leverage rehabilitation facilities and surgical units for clinical validation and patient recovery, and research institutes utilize biomechanics labs and medical device research centers to pioneer novel prototypes. Finally, material type segmentation differentiates composites-spanning carbon fiber architectures and polymeric composite blends-from steel and alloy constructs that range between heavy-duty frameworks and lightweight frame designs. This multi-dimensional view illuminates priority areas for investment, innovation, and go-to-market alignment.

Regional Market Variations Revealing Core Growth Drivers

Distinct regional trends have emerged, reflecting variations in regulatory frameworks, infrastructure maturity, and industrial priorities. In the Americas, advanced healthcare infrastructure and a growing emphasis on workplace ergonomics have accelerated adoption across both clinical rehabilitation and corporate wellness arenas. The region’s strong defense budgets have also catalyzed procurement of exoskeleton solutions that support soldier load carriage and training exercises.

In Europe, Middle East & Africa, collaborative R&D ecosystems and concerted regulatory alignment efforts have streamlined market entry for new technologies. Robust research funding in Western Europe and growing industrial automation demands in the Middle East have together fostered an environment conducive to pilot deployments in both manufacturing and healthcare settings.

Asia-Pacific’s rapid industrial growth and large workforce populations have driven significant investments in labor support technologies, with emphasis on automotive manufacturing hubs and logistics centers. Simultaneously, rising healthcare expenditures and aging demographics in countries such as Japan and South Korea have stimulated demand for rehabilitation and mobility assistance exoskeletons. These regional insights highlight where targeted go-to-market strategies can yield the greatest returns.

Insights into Leading Industry Players and Their Strategic Moves

Leading enterprises in the exoskeleton domain are refining their product portfolios through strategic partnerships, mergers, and targeted acquisitions. Industry pioneers specializing in rehabilitation technologies have forged alliances with robotics firms to embed advanced sensor suites and control algorithms into next-generation devices. Meanwhile, major industrial automation corporations have invested in in-house exoskeleton programs to complement their existing robotics offerings, aiming to deliver end-to-end solutions for manufacturing floors and logistics centers.

Innovators focusing on materials research have collaborated with academic institutions and composites manufacturers to develop proprietary lightweight structures that enhance wearer comfort without compromising load capacity. Strategic moves also include joint ventures with defense contractors to co-develop systems tailored for soldier mobility and endurance. Across these initiatives, the overarching trend is a drive toward vertically integrated supply chains and platform standardization, enabling faster time to market and coherent upgrade paths for end-users.

Actionable Strategies to Maintain Competitive Leadership in Exoskeletons

Industry leaders should prioritize the development of modular exoskeleton platforms that support rapid customization and scalable manufacturing. Advancements in composite materials must be matched by investments in adaptive control software that personalizes device behavior to individual user biomechanics. To navigate evolving trade landscapes, companies should explore nearshoring or localized assembly operations that mitigate tariff exposure while preserving supply chain agility.

Collaboration with rehabilitation specialists, ergonomists, and defense stakeholders will accelerate clinical validation and user acceptance. Simultaneously, vendors must strengthen after-sales support infrastructure-comprising training, maintenance, and software updates-to enhance total customer value and foster long-term partnerships. By channeling R&D spending toward energy-optimal actuation systems and AI-enabled diagnostics, manufacturers can position their product roadmaps to capitalize on rising demand for smart, connected exoskeleton ecosystems.

Rigorous Research Framework Underpinning Our Exoskeleton Analysis

This analysis synthesizes insights from a structured research framework that integrates both primary and secondary data sources. A comprehensive review of regulatory filings, patent databases, and technical standards provided foundational intelligence on device certification pathways and material innovations. Primary interviews with industry executives, end-user organizations, and key academic researchers enriched the quantitative data with qualitative perspectives on market dynamics and application use cases.

Data triangulation ensured consistency between public financial disclosures, corporate white papers, and independent test reports. The segmentation model was validated through cross-referencing company product catalogs and end-user purchase patterns. Geographic trends were corroborated using trade statistics and policy announcements. To maintain rigor, peer reviews and internal quality checkpoints were implemented at each stage of the research process, ensuring that the final insights reflect both the macroeconomic environment and on-the-ground realities experienced by manufacturers and users alike.

Concluding Perspectives on the Future of Exoskeleton Technologies

The exoskeleton market is on the cusp of sustained expansion as technological breakthroughs and strategic realignments converge to address pressing global needs across healthcare, industry, and defense. Key drivers include a demographic shift toward aging populations, mandatory ergonomics compliance in workplaces, and heightened defense modernization efforts. However, evolving trade policies and regulatory complexities necessitate agile supply chain and product strategies.

By leveraging the segmentation insights and regional analyses detailed in this report, stakeholders can prioritize high-impact opportunities and mitigate operational risks. The collective momentum of material science advances, integrated digital health platforms, and collaborative R&D initiatives points to a market that will reward those who act decisively and innovatively. With the right strategic focus, exoskeleton solutions will redefine human capability and unlock new value across sectors.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Product Type
    • Full Body Exoskeletons
      • Healthcare Applications
      • Military Applications
    • Lower Body Exoskeletons
      • Non-Powered Lower Body
        • Fitness & Rehabilitation
        • Orthopedic Uses
      • Powered Lower Body
        • Assistive Devices
        • Industrial Applications
    • Upper Body Exoskeletons
      • Chest Support
      • Medical Enhancements
      • Shoulder Support
  • Application
    • Accessibility Aids
      • Mobility Assistance
      • Physical Therapy
    • Healthcare
      • Elderly Assistance
      • Rehabilitation & Therapy
      • Surgical Assistance
    • Industrial
      • Automotive Manufacturing
      • Construction Assistance
      • Logistics & Warehousing
    • Military & Defense
      • Combat Readiness
      • Heavy Load Carriage
      • Pilot Assistance
  • End-User
    • Corporate
      • Corporate Wellness Programs
      • Workplace Ergonomics
    • End Consumers
      • Home Care
      • Personal Fitness
    • Hospitals & Clinics
      • Rehabilitation Facilities
      • Surgical Units
    • Research Institutes
      • Biomechanics Labs
      • Medical Device Research
  • Material Type
    • Composites
      • Carbon Fibers
      • Polymeric Composites
    • Steel & Alloys
      • Heavy-Duty Constructs
      • Lightweight Frames
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • ABLE Human Motion S.L.
  • B-Temia
  • Comau S.p.A.
  • CYBERDYNE INC.
  • Ekso Bionics Holdings, Inc.
  • German Bionic Systems GmbH
  • GOGOA MOBILITY ROBOTS, SL
  • HeroWear, LLC
  • Hocoma AG
  • Hyundai Motor Group
  • Laevo BV
  • Lifeward, Inc.
  • Lockheed Martin Corporation.
  • MAWASHI SCIENCE & TECHNOLOGY
  • Myomo Inc.
  • Ottobock SE
  • Panasonic Holdings Corporation
  • RB3D
  • Rex Bionics Ltd.
  • Robert Bosch GmbH
  • Shanghai Fourier Intelligence Co. Ltd.
  • Wandercraft

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
3.1. Exoskeleton Market's Emergence and Current Role Across Industries with Historical Milestones and Expansion Challenges
3.2. Quantitative Insights into Consumer Drivers, Competitive Strategies, and Regulatory Adaptation Across Regions
3.3. Market Lifecycle and IP Landscape Analysis with Strategic Roadmap and Competitive Barriers
3.4. Comprehensive Market Outlook, Strategic Growth Options, and Emerging Technological Trends Influencing Exoskeleton Evolution
4. Market Overview
4.1. Introduction
4.1.1. Exoskeleton Market: Defining its Global Economic Impact and Key Growth Catalysts
4.1.2. Regional Market Dynamics and Cultural Influences Shaping Exoskeleton Adoption Globally
4.1.3. Cutting-Edge Innovations and Strategic Expansions Driving the Exoskeleton Market Forward
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Integration of AI and machine learning to improve exoskeleton adaptability and performance
5.1.1. Understanding the Growing Role of AI and Machine Learning in Exoskeleton Adaptability and Performance
5.1.2. Strategic Shifts and Competitive Dynamics in Adapting to AI-Driven Exoskeleton Technologies
5.1.3. Future Trajectory and Strategic Imperatives of AI-Integrated Exoskeletons in the Coming Years
5.2. Implementation of exoskeletons in military training and combat support roles for enhanced soldier capabilities
5.2.1. Understanding the Surge in Military Exoskeleton Deployment and Its Market Drivers
5.2.2. Strategic Industry Adaptations in Response to Military Exoskeleton Innovations
5.2.3. Future Trajectory and Strategic Implications of Military Exoskeleton Deployment
5.3. Regulatory and safety standard developments impacting exoskeleton market growth and acceptance
5.3.1. Understanding Regulatory and Safety Standards Shaping the Exoskeleton Market Growth
5.3.2. How Regulatory Advances Drive Innovation and Market Expansion in Exoskeletons
5.3.3. Navigating Future Challenges and Benefits of Regulatory Trends in Exoskeleton Market
5.4. Rising investment and collaborations between tech firms and healthcare providers to innovate exoskeleton solutions
5.4.1. Defining the Surge in Tech-Healthcare Collaborations Revolutionizing Exoskeleton Innovations
5.4.2. Transforming Market Dynamics Through Strategic Tech-Healthcare Synergies in Exoskeleton Development
5.4.3. Future Outlook and Strategic Insights for Navigating the Evolving Exoskeleton Market Landscape
5.5. Increased focus on human-machine interface improvements for seamless exoskeleton control
5.5.1. Defining the trend of seamless human-machine interface advancements in exoskeletons
5.5.2. How improved human-machine interfaces are reshaping exoskeleton market opportunities
5.5.3. Future outlook and strategic considerations for human-machine interface enhancements in exoskeletons
5.6. Development of customized and modular exoskeletons for various user needs and industries
5.6.1. Understanding Customized and Modular Exoskeleton Developments in Diverse Markets
5.6.2. How Customization and Modularity are Revolutionizing Market Dynamics and Opportunities
5.6.3. Future Outlook and Strategic Considerations for Customized and Modular Exoskeletons
5.7. Growing adoption of exoskeletons in industrial sectors to reduce worker fatigue and injury risks
5.7.1. Understanding the Market Impact and Growth Drivers Behind Exoskeleton Adoption in Industry
5.7.2. Strategic Business Adaptations and Competitive Shifts Driven by Industrial Exoskeleton Use
5.7.3. Future Trajectory and Long-Term Strategic Implications of Industrial Exoskeleton Adoption
5.8. Advancements in battery technology extending exoskeleton operational duration and efficiency
5.8.1. Unlocking Extended Power: What Advancements in Battery Technology Mean for Exoskeletons
5.8.2. Strategic Shifts for Excellence: How Battery Breakthroughs Reshape Exoskeleton Business and Competition
5.8.3. Future Power Dynamics: The Evolution and Strategic Imperatives of Battery Advancements in Exoskeletons
5.9. Expansion of exoskeleton applications in medical rehabilitation and assistive technology
5.9.1. Understanding the Driving Forces Behind Exoskeleton Adoption in Medical and Assistive Sectors
5.9.2. Strategic Adaptations for Companies to Thrive Amid Growing Exoskeleton Integration
5.9.3. Future Outlook and Strategic Imperatives for Sustained Growth in Exoskeleton Applications
5.10. Emergence of lightweight and flexible exoskeleton designs for enhanced user comfort and mobility
5.10.1. Understanding the Rise of Lightweight and Flexible Exoskeletons Using Advanced Materials and Adaptive Technologies
5.10.2. Strategic Business Adaptations to Compete in a Market Driven by User-Centric Lightweight Exoskeleton Innovations
5.10.3. Future Trajectory of Lightweight Flexible Exoskeletons: Integration, Intensification, and Strategic Innovations
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.1.1. High entry barriers keep new competitors cautious in the exoskeleton market
6.1.2. Moderate substitution threat driven by evolving assistive technologies
6.1.3. Specialized suppliers exert strong influence on costs and supply continuity
6.1.4. Diverse buyers wield moderate influence shaping pricing and product features
6.1.5. Intense competition fuels innovation but pressures market profitability
6.2. PESTLE Analysis
6.2.1. Political stability and government policies crucially influence market growth and accessibility
6.2.2. Economic vitality and global financial dynamics dictate affordability and industrial demand
6.2.3. Evolving health consciousness and workplace safety culture fuel market demand
6.2.4. Cutting-edge robotics and AI innovation propel product advancement and market leadership
6.2.5. Regulatory compliance and IP protections shape market access and innovation security
6.2.6. Sustainability demands and climate risks drive eco-friendly innovation and operational resilience
7. Cumulative Impact of United States Tariffs 2025
7.1. Key U.S. Tariffs Shaping Market Dynamics from 2023 to 2025
7.2. Historical Evolution and Economic Intent Behind U.S. Tariffs Between 2018 and 2025
7.3. How U.S. Tariffs Have Directly Fueled Inflationary Pressures Globally
7.4. Trade Wars and Reciprocal Tariffs Highlight Rising Global Trade Tensions
7.5. Economic Disruptions and Political Strains on U.S. Trading Partners Due to Tariffs
7.6. Enduring Structural Shifts in U.S. Economy Driven by Tariff Policies
7.7. Strategic Policy Approaches to Alleviate Tariff-Induced Economic Challenges
8. Exoskeleton Market, by Product Type
8.1. Introduction
8.2. Full Body Exoskeletons
8.2.1. Healthcare Applications
8.2.2. Military Applications
8.3. Lower Body Exoskeletons
8.3.1. Non-Powered Lower Body
8.3.1.1. Fitness & Rehabilitation
8.3.1.2. Orthopedic Uses
8.3.2. Powered Lower Body
8.3.2.1. Assistive Devices
8.3.2.2. Industrial Applications
8.4. Upper Body Exoskeletons
8.4.1. Chest Support
8.4.2. Medical Enhancements
8.4.3. Shoulder Support
9. Exoskeleton Market, by Application
9.1. Introduction
9.2. Accessibility Aids
9.2.1. Mobility Assistance
9.2.2. Physical Therapy
9.3. Healthcare
9.3.1. Elderly Assistance
9.3.2. Rehabilitation & Therapy
9.3.3. Surgical Assistance
9.4. Industrial
9.4.1. Automotive Manufacturing
9.4.2. Construction Assistance
9.4.3. Logistics & Warehousing
9.5. Military & Defense
9.5.1. Combat Readiness
9.5.2. Heavy Load Carriage
9.5.3. Pilot Assistance
10. Exoskeleton Market, by End-User
10.1. Introduction
10.2. Corporate
10.2.1. Corporate Wellness Programs
10.2.2. Workplace Ergonomics
10.3. End Consumers
10.3.1. Home Care
10.3.2. Personal Fitness
10.4. Hospitals & Clinics
10.4.1. Rehabilitation Facilities
10.4.2. Surgical Units
10.5. Research Institutes
10.5.1. Biomechanics Labs
10.5.2. Medical Device Research
11. Exoskeleton Market, by Material Type
11.1. Introduction
11.2. Composites
11.2.1. Carbon Fibers
11.2.2. Polymeric Composites
11.3. Steel & Alloys
11.3.1. Heavy-Duty Constructs
11.3.2. Lightweight Frames
12. Americas Exoskeleton Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Exoskeleton Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Exoskeleton Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. ABLE Human Motion S.L.
15.3.1.1. From Inception to Niche Innovator: ABLE Human Motion's Market Entry and Current Standing
15.3.1.2. Innovative Mobility Solutions: Key Features and USPs of ABLE Human Motion's Flagship Exoskeleton
15.3.1.3. Mitigating Risks and Strengthening Market Position: Strategic Recommendations for ABLE Human Motion
15.3.2. B-Temia
15.3.2.1. Tracing B-Temia's Entry and Current Niche Standing in the Exoskeleton Market
15.3.2.2. Deep Dive into B-Temia's Innovative Exoskeleton Solutions and Market Appeal
15.3.2.3. Addressing Growth Risks and Strengthening B-Temia’s Competitive Edge for the Future
15.3.3. Comau S.p.A.
15.3.3.1. Strategic footprint and core competencies defining Comau's market leadership
15.3.3.2. Flagship exoskeleton innovations enhancing industrial workforce efficiency
15.3.3.3. Mitigating risks and leveraging innovation to secure Comau's growth future
15.3.4. CYBERDYNE INC.
15.3.4.1. From Market Entry to Leadership: CYBERDYNE's Evolution and Strategic Positioning
15.3.4.2. Revolutionizing Mobility: Deep Dive into CYBERDYNE's HAL Exoskeleton and Its Market Appeal
15.3.4.3. Navigating Challenges and Fortifying Growth: Strategic Roadmap for CYBERDYNE's Future Success
15.3.5. Ekso Bionics Holdings, Inc.
15.3.5.1. Ekso Bionics' Strategic Market Role and Core Strengths Driving Growth and Innovation
15.3.5.2. Flagship Exoskeleton Devices Demonstrating Advanced Functionality and Market Leadership
15.3.5.3. Mitigating Risks and Leveraging Innovation to Strengthen Market Position and Expand Horizons
15.3.6. German Bionic Systems GmbH
15.3.6.1. From Market Entry to Challenger Status: German Bionic Systems' Strategic Journey
15.3.6.2. Cray X Exoskeleton: A User-Centered Innovation Transforming Industrial Labor
15.3.6.3. Navigating Challenges and Strengthening German Bionic's Market Position for Future Success
15.3.7. GOGOA MOBILITY ROBOTS, SL
15.3.7.1. GOGOA Mobility Robots' Market Entry and Current Strategic Positioning
15.3.7.2. Flagship Exoskeleton Products and Unique Market Differentiators
15.3.7.3. Risk Assessment and Strategic Pathways for Sustainable Growth
15.3.8. HeroWear, LLC
15.3.8.1. HeroWear's Market Entry, Growth Milestones, and Competitive Positioning
15.3.8.2. HeroWear’s Atlas Exoskeleton: Key Features and Differentiation in Industrial Wearable Tech
15.3.8.3. Addressing HeroWear’s Risks and Crafting Strategies for Sustainable Growth
15.3.9. Hocoma AG
15.3.9.1. Tracing Hocoma AG’s Market Entry, Evolution, and Current Global Positioning
15.3.9.2. In-Depth Examination of Hocoma AG’s Flagship Robotic Rehabilitation Solutions
15.3.9.3. Assessing Risks and Proposing Strategic Initiatives for Hocoma AG’s Sustainable Growth
15.3.10. Hyundai Motor Group
15.3.10.1. From Humble Beginnings to Global Leadership in Electric and Smart Mobility
15.3.10.2. Innovative Electric and Hydrogen Vehicles Define Hyundai’s Competitive Edge
15.3.10.3. Navigating Competitive and Technological Risks with Strategic Innovation and Diversification
15.3.11. Laevo BV
15.3.11.1. Laevo BV's Strategic Market Positioning and Core Strengths in the Exoskeleton Industry
15.3.11.2. In-Depth Review of Laevo BV's Flagship Exoskeleton and Consumer Alignment
15.3.11.3. Mitigating Risks and Strategic Growth Opportunities for Laevo BV in a Dynamic Market
15.3.12. Lifeward, Inc.
15.3.12.1. Lifeward’s market entry, strategic evolution, and dynamic positioning in the exoskeleton industry
15.3.12.2. In-depth analysis of Lifeward's flagship exoskeletons and their unique market value
15.3.12.3. Addressing risks and leveraging strategies for Lifeward’s sustainable growth and market resilience
15.3.13. Lockheed Martin Corporation.
15.3.13.1. Lockheed Martin’s Strategic Dominance and Global Market Presence Shaping Its Defense Leadership
15.3.13.2. Flagship Aerospace and Defense Solutions Propelling Lockheed Martin's Market Leadership
15.3.13.3. Navigating Challenges and Seizing Strategic Opportunities for Sustainable Growth
15.3.14. MAWASHI SCIENCE & TECHNOLOGY
15.3.14.1. Tracing Mawashi Science & Technology’s Evolution and Market Positioning in Exoskeletons
15.3.14.2. In-depth Exploration of Mawashi’s Flagship Exoskeleton Solutions and Their Market Appeal
15.3.14.3. Mitigating Risks and Strengthening Mawashi’s Competitive Edge for Sustainable Growth
15.3.15. Myomo Inc.
15.3.15.1. Myomo Inc.’s Strategic Market Position and Core Strengths Driving Healthcare Innovation
15.3.15.2. MyoPro Powered Arm Orthosis: Transforming Upper Limb Mobility with Advanced Assistive Tech
15.3.15.3. Addressing Growth Risks and Leveraging Innovation for Myomo’s Future Market Leadership
15.3.16. Ottobock SE
15.3.16.1. Ottobock SE's Strategic Footprint and Leadership in the Global Exoskeleton Market
15.3.16.2. Innovation and User-Centric Excellence in Ottobock's Flagship Mobility Solutions
15.3.16.3. Navigating Risks and Capitalizing on Future Trends for Sustainable Growth in Mobility Tech
15.3.17. Panasonic Holdings Corporation
15.3.17.1. Panasonic Holdings Corporation’s strategic foundation and global market presence
15.3.17.2. Flagship innovations and unique product strengths tailored to evolving consumer demands
15.3.17.3. Navigating competitive risks and strategic growth pathways for sustained market leadership
15.3.18. RB3D
15.3.18.1. RB3D's Market Entry, Strategic Evolution, and Competitive Positioning
15.3.18.2. RB3D's Flagship Products and Unique Selling Propositions (USPs)
15.3.18.3. RB3D's Risks and Growth Strategies
15.3.19. Rex Bionics Ltd.
15.3.19.1. Rex Bionics’ Market Entry, Evolution, and Strategic Position in a Competitive Landscape
15.3.19.2. Deep Dive into Rex Bionics’ Flagship Exoskeleton: Innovation Tailored for Mobility Empowerment
15.3.19.3. Navigating Risks and Strengthening Rex Bionics’ Market Resilience through Strategic Innovation
15.3.20. Robert Bosch GmbH
15.3.20.1. Bosch's Strategic Market Position and Core Strengths in the Exoskeleton Industry
15.3.20.2. Innovative Features and Market Alignment of Bosch’s Flagship Exoskeletons
15.3.20.3. Navigating Risks and Strategic Growth Opportunities for Bosch’s Exoskeleton Business
15.3.21. Shanghai Fourier Intelligence Co. Ltd.
15.3.21.1. Shanghai Fourier Intelligence’s strategic foundation and market footprint in rehabilitation robotics
15.3.21.2. Innovative intelligent rehabilitation robots driving personalized patient recovery
15.3.21.3. Addressing innovation and market risks to future-proof growth in rehabilitation technology
15.3.22. Wandercraft
15.3.22.1. Wandercraft's Market Entry, Evolution, and Strategic Positioning in the Exoskeleton Industry
15.3.22.2. In-Depth Look at Wandercraft's Atalante Exoskeleton and Its Market Differentiators
15.3.22.3. Addressing Wandercraft's Risks and Strategic Actions for Sustainable Growth
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. EXOSKELETON MARKET MULTI-CURRENCY
FIGURE 2. EXOSKELETON MARKET MULTI-LANGUAGE
FIGURE 3. EXOSKELETON MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL EXOSKELETON MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL EXOSKELETON MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL EXOSKELETON MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL EXOSKELETON MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL EXOSKELETON MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL EXOSKELETON MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL EXOSKELETON MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL EXOSKELETON MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL EXOSKELETON MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL EXOSKELETON MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL EXOSKELETON MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS EXOSKELETON MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS EXOSKELETON MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES EXOSKELETON MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES EXOSKELETON MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA EXOSKELETON MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA EXOSKELETON MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC EXOSKELETON MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC EXOSKELETON MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EXOSKELETON MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. EXOSKELETON MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. EXOSKELETON MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL EXOSKELETON MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL EXOSKELETON MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL EXOSKELETON MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL EXOSKELETON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL EXOSKELETON MARKET SIZE, BY FULL BODY EXOSKELETONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL EXOSKELETON MARKET SIZE, BY HEALTHCARE APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL EXOSKELETON MARKET SIZE, BY MILITARY APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL EXOSKELETON MARKET SIZE, BY FULL BODY EXOSKELETONS, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL EXOSKELETON MARKET SIZE, BY LOWER BODY EXOSKELETONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL EXOSKELETON MARKET SIZE, BY NON-POWERED LOWER BODY, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL EXOSKELETON MARKET SIZE, BY FITNESS & REHABILITATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL EXOSKELETON MARKET SIZE, BY ORTHOPEDIC USES, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL EXOSKELETON MARKET SIZE, BY NON-POWERED LOWER BODY, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL EXOSKELETON MARKET SIZE, BY POWERED LOWER BODY, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL EXOSKELETON MARKET SIZE, BY ASSISTIVE DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL EXOSKELETON MARKET SIZE, BY INDUSTRIAL APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL EXOSKELETON MARKET SIZE, BY POWERED LOWER BODY, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL EXOSKELETON MARKET SIZE, BY LOWER BODY EXOSKELETONS, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL EXOSKELETON MARKET SIZE, BY UPPER BODY EXOSKELETONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL EXOSKELETON MARKET SIZE, BY CHEST SUPPORT, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL EXOSKELETON MARKET SIZE, BY MEDICAL ENHANCEMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL EXOSKELETON MARKET SIZE, BY SHOULDER SUPPORT, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL EXOSKELETON MARKET SIZE, BY UPPER BODY EXOSKELETONS, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL EXOSKELETON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL EXOSKELETON MARKET SIZE, BY ACCESSIBILITY AIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL EXOSKELETON MARKET SIZE, BY MOBILITY ASSISTANCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL EXOSKELETON MARKET SIZE, BY PHYSICAL THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL EXOSKELETON MARKET SIZE, BY ACCESSIBILITY AIDS, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL EXOSKELETON MARKET SIZE, BY HEALTHCARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL EXOSKELETON MARKET SIZE, BY ELDERLY ASSISTANCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL EXOSKELETON MARKET SIZE, BY REHABILITATION & THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL EXOSKELETON MARKET SIZE, BY SURGICAL ASSISTANCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL EXOSKELETON MARKET SIZE, BY HEALTHCARE, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL EXOSKELETON MARKET SIZE, BY INDUSTRIAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL EXOSKELETON MARKET SIZE, BY AUTOMOTIVE MANUFACTURING, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL EXOSKELETON MARKET SIZE, BY CONSTRUCTION ASSISTANCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL EXOSKELETON MARKET SIZE, BY LOGISTICS & WAREHOUSING, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL EXOSKELETON MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL EXOSKELETON MARKET SIZE, BY MILITARY & DEFENSE, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL EXOSKELETON MARKET SIZE, BY COMBAT READINESS, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL EXOSKELETON MARKET SIZE, BY HEAVY LOAD CARRIAGE, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL EXOSKELETON MARKET SIZE, BY PILOT ASSISTANCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL EXOSKELETON MARKET SIZE, BY MILITARY & DEFENSE, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL EXOSKELETON MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL EXOSKELETON MARKET SIZE, BY CORPORATE, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL EXOSKELETON MARKET SIZE, BY CORPORATE WELLNESS PROGRAMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL EXOSKELETON MARKET SIZE, BY WORKPLACE ERGONOMICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL EXOSKELETON MARKET SIZE, BY CORPORATE, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL EXOSKELETON MARKET SIZE, BY END CONSUMERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL EXOSKELETON MARKET SIZE, BY HOME CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL EXOSKELETON MARKET SIZE, BY PERSONAL FITNESS, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL EXOSKELETON MARKET SIZE, BY END CONSUMERS, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL EXOSKELETON MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL EXOSKELETON MARKET SIZE, BY REHABILITATION FACILITIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL EXOSKELETON MARKET SIZE, BY SURGICAL UNITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL EXOSKELETON MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL EXOSKELETON MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL EXOSKELETON MARKET SIZE, BY BIOMECHANICS LABS, BY REGION, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL EXOSKELETON MARKET SIZE, BY MEDICAL DEVICE RESEARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL EXOSKELETON MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL EXOSKELETON MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL EXOSKELETON MARKET SIZE, BY COMPOSITES, BY REGION, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL EXOSKELETON MARKET SIZE, BY CARBON FIBERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 66. GLOBAL EXOSKELETON MARKET SIZE, BY POLYMERIC COMPOSITES, BY REGION, 2018-2030 (USD MILLION)
TABLE 67. GLOBAL EXOSKELETON MARKET SIZE, BY COMPOSITES, 2018-2030 (USD MILLION)
TABLE 68. GLOBAL EXOSKELETON MARKET SIZE, BY STEEL & ALLOYS, BY REGION, 2018-2030 (USD MILLION)
TABLE 69. GLOBAL EXOSKELETON MARKET SIZE, BY HEAVY-DUTY CONSTRUCTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 70. GLOBAL EXOSKELETON MARKET SIZE, BY LIGHTWEIGHT FRAMES, BY REGION, 2018-2030 (USD MILLION)
TABLE 71. GLOBAL EXOSKELETON MARKET SIZE, BY STEEL & ALLOYS, 2018-2030 (USD MILLION)
TABLE 72. AMERICAS EXOSKELETON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 73. AMERICAS EXOSKELETON MARKET SIZE, BY FULL BODY EXOSKELETONS, 2018-2030 (USD MILLION)
TABLE 74. AMERICAS EXOSKELETON MARKET SIZE, BY LOWER BODY EXOSKELETONS, 2018-2030 (USD MILLION)
TABLE 75. AMERICAS EXOSKELETON MARKET SIZE, BY NON-POWERED LOWER BODY, 2018-2030 (USD MILLION)
TABLE 76. AMERICAS EXOSKELETON MARKET SIZE, BY POWERED LOWER BODY, 2018-2030 (USD MILLION)
TABLE 77. AMERICAS EXOSKELETON MARKET SIZE, BY UPPER BODY EXOSKELETONS, 2018-2030 (USD MILLION)
TABLE 78. AMERICAS EXOSKELETON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 79. AMERICAS EXOSKELETON MARKET SIZE, BY ACCESSIBILITY AIDS, 2018-2030 (USD MILLION)
TABLE 80. AMERICAS EXOSKELETON MARKET SIZE, BY HEALTHCARE, 2018-2030 (USD MILLION)
TABLE 81. AMERICAS EXOSKELETON MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
TABLE 82. AMERICAS EXOSKELETON MARKET SIZE, BY MILITARY & DEFENSE, 2018-2030 (USD MILLION)
TABLE 83. AMERICAS EXOSKELETON MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 84. AMERICAS EXOSKELETON MARKET SIZE, BY CORPORATE, 2018-2030 (USD MILLION)
TABLE 85. AMERICAS EXOSKELETON MARKET SIZE, BY END CONSUMERS, 2018-2030 (USD MILLION)
TABLE 86. AMERICAS EXOSKELETON MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 87. AMERICAS EXOSKELETON MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 88. AMERICAS EXOSKELETON MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 89. AMERICAS EXOSKELETON MARKET SIZE, BY COMPOSITES, 2018-2030 (USD MILLION)
TABLE 90. AMERICAS EXOSKELETON MARKET SIZE, BY STEEL & ALLOYS, 2018-2030 (USD MILLION)
TABLE 91. AMERICAS EXOSKELETON MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 92. UNITED STATES EXOSKELETON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 93. UNITED STATES EXOSKELETON MARKET SIZE, BY FULL BODY EXOSKELETONS, 2018-2030 (USD MILLION)
TABLE 94. UNITED STATES EXOSKELETON MARKET SIZE, BY LOWER BODY EXOSKELETONS, 2018-2030 (USD MILLION)
TABLE 95. UNITED STATES EXOSKELETON MARKET SIZE, BY NON-POWERED LOWER BODY, 2018-2030 (USD MILLION)
TABLE 96. UNITED STATES EXOSKELETON MARKET SIZE, BY POWERED LOWER BODY, 2018-2030 (USD MILLION)
TABLE 97. UNITED STATES EXOSKELETON MARKET SIZE, BY UPPER BODY EXOSKELETONS, 2018-2030 (USD MILLION)
TABLE 98. UNITED STATES EXOSKELETON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 99. UNITED STATES EXOSKELETON MARKET SIZE, BY ACCESSIBILITY AIDS, 2018-2030 (USD MILLION)
TABLE 100. UNITED STATES EXOSKELETON MARKET SIZE, BY HEALTHCARE, 2018-2030 (USD MILLION)
TABLE 101. UNITED STATES EXOSKELETON MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
TABLE 102. UNITED STATES EXOSKELETON MARKET SIZE, BY MILITARY & DEFENSE, 2018-2030 (USD MILLION)
TABLE 103. UNITED STATES EXOSKELETON MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 104. UNITED STATES EXOSKELETON MARKET SIZE, BY CORPORATE, 2018-2030 (USD MILLION)
TABLE 105. UNITED STATES EXOSKELETON MARKET SIZE, BY END CONSUMERS, 2018-2030 (USD MILLION)
TABLE 106. UNITED STATES EXOSKELETON MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 107. UNITED STATES EXOSKELETON MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 108. UNITED STATES EXOSKELETON MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 109. UNITED STATES EXOSKELETON MARKET SIZE, BY COMPOSITES, 2018-2030 (USD MILLION)
TABLE 110. UNITED STATES EXOSKELETON MARKET SIZE, BY STEEL & ALLOYS, 2018-2030 (USD MILLION)
TABLE 111. UNITED STATES EXOSKELETON MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 112. CANADA EXOSKELETON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 113. CANADA EXOSKELETON MARKET SIZE, BY FULL BODY EXOSKELETONS, 2018-2030 (USD MILLION)
TABLE 114. CANADA EXOSKELETON MARKET SIZE, BY LOWER BODY EXOSKELETONS, 2018-2030 (USD MILLION)
TABLE 115. CANADA EXOSKELETON MARKET SIZE, BY NON-POWERED LOWER BODY, 2018-2030 (USD MILLION)
TABLE 116. CANADA EXOSKELETON MARKET SIZE, BY POWERED LOWER BODY, 2018-2030 (USD MILLION)
TABLE 117. CANADA EXOSKELETON MARKET SIZE, BY UPPER BODY EXOSKELETONS, 2018-2030 (USD MILLION)
TABLE 118. CANADA EXOSKELETON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 119. CANADA EXOSKELETON MARKET SIZE, BY ACCESSIBILITY AIDS, 2018-2030 (USD MILLION)
TABLE 120. CANADA EXOSKELETON MARKET SIZE, BY HEALTHCARE, 2018-2030 (USD MILLION)
TABLE 121. CANADA EXOSKELETON MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
TABLE 122. CANADA EXOSKELETON MARKET SIZE, BY MILITARY & DEFENSE, 2018-2030 (USD MILLION)
TABLE 123. CANADA EXOSKELETON MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 124. CANADA EXOSKELETON MARKET SIZE, BY CORPORATE, 2018-2030 (USD MILLION)
TABLE 125. CANADA EXOSKELETON MARKET SIZE, BY END CONSUMERS, 2018-2030 (USD MILLION)
TABLE 126. CANADA EXOSKELETON MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 127. CANADA EXOSKELETON MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 128. CANADA EXOSKELETON MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 129. CANADA EXOSKELETON MARKET SIZE, BY COMPOSITES, 2018-2030 (USD MILLION)
TABLE 130. CANADA EXOSKELETON MARKET SIZE, BY STEEL & ALLOYS, 2018-2030 (USD MILLION)
TABLE 131. MEXICO EXOSKELETON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 132. MEXICO EXOSKELETON MARKET SIZE, BY FULL BODY EXOSKELETONS, 2018-2030 (USD MILLION)
TABLE 133. MEXICO EXOSKELETON MARKET SIZE, BY LOWER BODY EXOSKELETONS, 2018-2030 (USD MILLION)
TABLE 134. MEXICO EXOSKELETON MARKET SIZE, BY NON-POWERED LOWER BODY, 2018-2030 (USD MILLION)
TABLE 135. MEXICO EXOSKELETON MARKET SIZE, BY POWERED LOWER BODY, 2018-2030 (USD MILLION)
TABLE 136. MEXICO EXOSKELETON MARKET SIZE, BY UPPER BODY EXOSKELETONS, 2018-2030 (USD MILLION)
TABLE 137. MEXICO EXOSKELETON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 138. MEXICO EXOSKELETON MARKET SIZE, BY ACCESSIBILITY AIDS, 2018-2030 (USD MILLION)
TABLE 139. MEXICO EXOSKELETON MARKET SIZE, BY HEALTHCARE, 2018-2030 (USD MILLION)
TABLE 140. MEXICO EXOSKELETON MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
TABLE 141. MEXICO EXOSKELETON MARKET SIZE, BY MILITARY & DEFENSE, 2018-2030 (USD MILLION)
TABLE 142. MEXICO EXOSKELETON MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 143. MEXICO EXOSKELETON MARKET SIZE, BY CORPORATE, 2018-2030 (USD MILLION)
TABLE 144. MEXICO EXOSKELETON MARKET SIZE, BY END CONSUMERS, 2018-2030 (USD MILLION)
TABLE 145. MEXICO EXOSKELETON MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 146. MEXICO EXOSKELETON MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 147. MEXICO EXOSKELETON MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 148. MEXICO EXOSKELETON MARKET SIZE, BY COMPOSITES, 2018-2030 (USD MILLION)
TABLE 149. MEXICO EXOSKELETON MARKET SIZE, BY STEEL & ALLOYS, 2018-2030 (USD MILLION)
TABLE 150. BRAZIL EXOSKELETON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 151. BRAZIL EXOSKELETON MARKET SIZE, BY FULL BODY EXOSKELETONS, 2018-2030 (USD MILLION)
TABLE 152. BRAZIL EXOSKELETON MARKET SIZE, BY LOWER BODY EXOSKELETONS, 2018-2030 (USD MILLION)
TABLE 153. BRAZIL EXOSKELETON MARKET SIZE, BY NON-POWERED LOWER BODY, 2018-2030 (USD MILLION)
TABLE 154. BRAZIL EXOSKELETON MARKET SIZE, BY POWERED LOWER BODY, 2018-2030 (USD MILLION)
TABLE 155. BRAZIL EXOSKELETON MARKET SIZE, BY UPPER BODY EXOSKELETONS, 2018-2030 (USD MILLION)
TABLE 156. BRAZIL EXOSKELETON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 157. BRAZIL EXOSKELETON MARKET SIZE, BY ACCESSIBILITY AIDS, 2018-2030 (USD MILLION)
TABLE 158. BRAZIL EXOSKELETON MARKET SIZE, BY HEALTHCARE, 2018-2030 (USD MILLION)
TABLE 159. BRAZIL EXOSKELETON MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
TABLE 160. BRAZIL EXOSKELETON MARKET SIZE, BY MILITARY & DEFENSE, 2018-2030 (USD MILLION)
TABLE 161. BRAZIL EXOSKELETON MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 162. BRAZIL EXOSKELETON MARKET SIZE, BY CORPORATE, 2018-2030 (USD MILLION)
TABLE 163. BRAZIL EXOSKELETON MARKET SIZE, BY END CONSUMERS, 2018-2030 (USD MILLION)
TABLE 164. BRAZIL EXOSKELETON MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 165. BRAZIL EXOSKELETON MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 166. BRAZIL EXOSKELETON MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 167. BRAZIL EXOSKELETON MARKET SIZE, BY COMPOSITES, 2018-2030 (USD MILLION)
TABLE 168. BRAZIL EXOSKELETON MARKET SIZE, BY STEEL & ALLOYS, 2018-2030 (USD MILLION)
TABLE 169. ARGENTINA EXOSKELETON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 170. ARGENTINA EXOSKELETON MARKET SIZE, BY FULL BODY EXOSKELETONS, 2018-2030 (USD MILLION)
TABLE 171. ARGENTINA EXOSKELETON MARKET SIZE, BY LOWER BODY EXOSKELETONS, 2018-2030 (USD MILLION)
TABLE 172. ARGENTINA EXOSKELETON MARKET SIZE, BY NON-POWERED LOWER BODY, 2018-2030 (USD MILLION)
TABLE 173. ARGENTINA EXOSKELETON MARKET SIZE, BY POWERED LOWER BODY, 2018-2030 (USD MILLION)
TABLE 174. ARGENTINA EXOSKELETON MARKET SIZE, BY UPPER BODY EXOSKELETONS, 2018-2030 (USD MILLION)
TABLE 175. ARGENTINA EXOSKELETON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 176. ARGENTINA EXOSKELETON MARKET SIZE, BY ACCESSIBILITY AIDS, 2018-2030 (USD MILLION)
TABLE 177. ARGENTINA EXOSKELETON MARKET SIZE, BY HEALTHCARE, 2018-2030 (USD MILLION)
TABLE 178. ARGENTINA EXOSKELETON MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
TABLE 179. ARGENTINA EXOSKELETON MARKET SIZE, BY MILITARY & DEFENSE, 2018-2030 (USD MILLION)
TABLE 180. ARGENTINA EXOSKELETON MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 181. ARGENTINA EXOSKELETON MARKET SIZE, BY CORPORATE, 2018-2030 (USD MILLION)
TABLE 182. ARGENTINA EXOSKELETON MARKET SIZE, BY END CONSUMERS, 2018-2030 (USD MILLION)
TABLE 183. ARGENTINA EXOSKELETON MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 184. ARGENTINA EXOSKELETON MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 185. ARGENTINA EXOSKELETON MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 186. ARGENTINA EXOSKELETON MARKET SIZE, BY COMPOSITES, 2018-2030 (USD MILLION)
TABLE 187. ARGENTINA EXOSKELETON MARKET SIZE, BY STEEL & ALLOYS, 2018-2030 (USD MILLION)
TABLE 188. EUROPE, MIDDLE EAST & AFRICA EXOSKELETON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 189. EUROPE, MIDDLE EAST & AFRICA EXOSKELETON MARKET SIZE, BY FULL BODY EXOSKELETONS, 2018-2030 (USD MILLION)
TABLE 190. EUROPE, MIDDLE EAST & AFRICA EXOSKELETON MARKET SIZE, BY LOWER BODY EXOSKELETONS, 2018-2030 (USD MILLION)
TABLE 191. EUROPE, MIDDLE EAST & AFRICA EXOSKELETON MARKET SIZE, BY NON-POWERED LOWER BODY, 2018-2030 (USD MILLION)
TABLE 192. EUROPE, MIDDLE EAST & AFRICA EXOSKELETON MARKET SIZE, BY POWERED LOWER BODY, 2018-2030 (USD MILLION)
TABLE 193. EUROPE, MIDDLE EAST & AFRICA EXOSKELETON MARKET SIZE, BY UPPER BODY EXOSKELETONS, 2018-2030 (USD MILLION)
TABLE 194. EUROPE, MIDDLE EAST & AFRICA EXOSKELETON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 195. EUROPE, MIDDLE EAST & AFRICA EXOSKELETON MARKET SIZE, BY ACCESSIBILITY AIDS, 2018-2030 (USD MILLION)
TABLE 196. EUROPE, MIDDLE EAST & AFRICA EXOSKELETON MARKET SIZE, BY HEALTHCARE, 2018-2030 (USD MILLION)
TABLE 197. EUROPE, MIDDLE EAST & AFRICA EXOSKELETON MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
TABLE 198. EUROPE, MIDDLE EAST & AFRICA EXOSKELETON MARKET SIZE, BY MILITARY & DEFENSE, 2018-2030 (USD MILLION)
TABLE 199. EUROPE, MIDDLE EAST & AFRICA EXOSKELETON MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 200. EUROPE, MIDDLE EAST & AFRICA EXOSKELETON MARKET SIZE, BY CORPORATE, 2018-2030 (USD MILLION)
TABLE 201. EUROPE, MIDDLE EAST & AFRICA EXOSKELETON MARKET SIZE, BY END CONSUMERS, 2018-2030 (USD MILLION)
TABLE 202. EUROPE, MIDDLE EAST & AFRICA EXOSKELETON MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 203. EUROPE, MIDDLE EAST & AFRICA EXOSKELETON MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 204. EUROPE, MIDDLE EAST & AFRICA EXOSKELETON MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 205. EUROPE, MIDDLE EAST & AFRICA EXOSKELETON MARKET SIZE, BY COMPOSITES, 2018-2030 (USD MILLION)
TABLE 206. EUROPE, MIDDLE EAST & AFRICA EXOSKELETON MARKET SIZE, BY STEEL & ALLOYS, 2018-2030 (USD MILLION)
TABLE 207. EUROPE, MIDDLE EAST & AFRICA EXOSKELETON MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 208. UNITED KINGDOM EXOSKELETON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 209. UNITED KINGDOM EXOSKELETON MARKET SIZE, BY FULL BODY EXOSKELETONS, 2018-2030 (USD MILLION)
TABLE 210. UNITED KINGDOM EXOSKELETON MARKET SIZE, BY LOWER BODY EXOSKELETONS, 2018-2030 (USD MILLION)
TABLE 211. UNITED KINGDOM EXOSKELETON MARKET SIZE, BY NON-POWERED LOWER BODY, 2018-2030 (USD MILLION)
TABLE 212. UNITED KINGDOM EXOSKELETON MARKET SIZE, BY POWERED LOWER BODY, 2018-2030 (USD MILLION)
TABLE 213. UNITED KINGDOM EXOSKELETON MARKET SIZE, BY UPPER BODY EXOSKELETONS, 2018-2030 (USD MILLION)
TABLE 214. UNITED KINGDOM EXOSKELETON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 215. UNITED KINGDOM EXOSKELETON MARKET SIZE, BY ACCESSIBILITY AIDS, 2018-2030 (USD MILLION)
TABLE 216. UNITED KINGDOM EXOSKELETON MARKET SIZE, BY HEALTHCARE, 2018-2030 (USD MILLION)
TABLE 217. UNITED KINGDOM EXOSKELETON MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
TABLE 218. UNITED KINGDOM EXOSKELETON MARKET SIZE, BY MILITARY & DEFENSE, 2018-2030 (USD MILLION)
TABLE 219. UNITED KINGDOM EXOSKELETON MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 220. UNITED KINGDOM EXOSKELETON MARKET SIZE, BY CORPORATE, 2018-2030 (USD MILLION)
TABLE 221. UNITED KINGDOM EXOSKELETON MARKET SIZE, BY END CONSUMERS, 2018-2030 (USD MILLION)
TABLE 222. UNITED KINGDOM EXOSKELETON MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 223. UNITED KINGDOM EXOSKELETON MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 224. UNITED KINGDOM EXOSKELETON MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 225. UNITED KINGDOM EXOSKELETON MARKET SIZE, BY COMPOSITES, 2018-2030 (USD MILLION)
TABLE 226. UNITED KINGDOM EXOSKELETON MARKET SIZE, BY STEEL & ALLOYS, 2018-2030 (USD MILLION)
TABLE 227. GERMANY EXOSKELETON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 228. GERMANY EXOSKELETON MARKET SIZE, BY FULL BODY EXOSKELETONS, 2018-2030 (USD MILLION)
TABLE 229. GERMANY EXOSKELETON MARKET SIZE, BY LOWER BODY EXOSKELETONS, 2018-2030 (USD MILLION)
TABLE 230. GERMANY EXOSKELETON MARKET SIZE, BY NON-POWERED LOWER BODY, 2018-2030 (USD MILLION)
TABLE 231. GERMANY EXOSKELETON MARKET SIZE, BY POWERED LOWER BODY, 2018-2030 (USD MILLION)
TABLE 232. GERMANY EXOSKELETON MARKET SIZE, BY UPPER BODY EXOSKELETONS, 2018-2030 (USD MILLION)
TABLE 233. GERMANY EXOSKELETON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 234. GERMANY EXOSKELETON MARKET SIZE, BY ACCESSIBILITY AIDS, 2018-2030 (USD MILLION)
TABLE 235. GERMANY EXOSKELETON MARKET SIZE, BY HEALTHCARE, 2018-2030 (USD MILLION)
TABLE 236. GERMANY EXOSKELETON MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
TABLE 237. GERMANY EXOSKELETON MARKET SIZE, BY MILITARY & DEFENSE, 2018-2030 (USD MILLION)
TABLE 238. GERMANY EXOSKELETON MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 239. GERMANY EXOSKELETON MARKET SIZE, BY CORPORATE, 2018-2030 (USD MILLION)
TABLE 240. GERMANY EXOSKELETON MARKET SIZE, BY END CONSUMERS, 2018-2030 (USD MILLION)
TABLE 241. GERMANY EXOSKELETON MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 242. GERMANY EXOSKELETON MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 243. GERMANY EXOSKELETON MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 244. GERMANY EXOSKELETON MARKET SIZE, BY COMPOSITES, 2018-2030 (USD MILLION)
TABLE 245. GERMANY EXOSKELETON MARKET SIZE, BY STEEL & ALLOYS, 2018-2030 (USD MILLION)
TABLE 246. FRANCE EXOSKELETON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 247. FRANCE EXOSKELETON MARKET SIZE, BY FULL BODY EXOSKELETONS, 2018-2030 (USD MILLION)
TABLE 248. FRANCE EXOSKELETON MARKET SIZE, BY LOWER BODY EXOSKELETONS, 2018-2030 (USD MILLION)
TABLE 249. FRANCE EXOSKELETON MARKET SIZE, BY NON-POWERED LOWER BODY, 2018-2030 (USD MILLION)
TABLE 250. FRANCE EXOSKELETON MARKET SIZE, BY POWERED LOWER BODY, 2018-2030 (USD MILLION)
TABLE 251. FRANCE EXOSKELETON MARKET SIZE, BY UPPER BODY EXOSKELETONS, 2018-2030 (USD MILLION)
TABLE 252. FRANCE EXOSKELETON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 253. FRANCE EXOSKELETON MARKET SIZE, BY ACCESSIBILITY AIDS, 2018-2030 (USD MILLION)
TABLE 254. FRANCE EXOSKELETON MARKET SIZE, BY HEALTHCARE, 2018-2030 (USD MILLION)
TABLE 255. FRANCE EXOSKELETON MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
TABLE 256. FRANCE EXOSKELETON MARKET SIZE, BY MILITARY & DEFENSE, 2018-2030 (USD MILLION)
TABLE 257. FRANCE EXOSKELETON MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 258. FRANCE EXOSKELETON MARKET SIZE, BY CORPORATE, 2018-2030 (USD MILLION)
TABLE 259. FRANCE EXOSKELETON MARKET SIZE, BY END CONSUMERS, 2018-2030 (USD MILLION)
TABLE 260. FRANCE EXOSKELETON MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 261. FRANCE EXOSKELETON MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 262. FRANCE EXOSKELETON MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 263. FRANCE EXOSKELETON MARKET SIZE, BY COMPOSITES, 2018-2030 (USD MILLION)
TABLE 264. FRANCE EXOSKELETON MARKET SIZE, BY STEEL & ALLOYS, 2018-2030 (USD MILLION)
TABLE 265. RUSSIA EXOSKELETON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 266. RUSSIA EXOSKELETON MARKET SIZE, BY FULL BODY EXOSKELETONS, 2018-2030 (USD MILLION)
TABLE 267. RUSSIA EXOSKELETON MARKET SIZE, BY LOWER BODY EXOSKELETONS, 2018-2030 (USD MILLION)
TABLE 268. RUSSIA EXOSKELETON MARKET SIZE, BY NON-POWERED LOWER BODY, 2018-2030 (USD MILLION)
TABLE 269. RUSSIA EXOSKELETON MARKET SIZE, BY POWERED LOWER BODY, 2018-2030 (USD MILLION)
TABLE 270. RUSSIA EXOSKELETON MARKET SIZE, BY UPPER BODY EXOSKELETONS, 2018-2030 (USD MILLION)
TABLE 271. RUSSIA EXOSKELETON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 272. RUSSIA EXOSKELETON MARKET SIZE, BY ACCESSIBILITY AIDS, 2018-2030 (USD MILLION)
TABLE 273. RUSSIA EXOSKELETON MARKET SIZE, BY HEALTHCARE, 2018-2030 (USD MILLION)
TABLE 274. RUSSIA EXOSKELETON MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
TABLE 275. RUSSIA EXOSKELETON MARKET SIZE, BY MILITARY & DEFENSE, 2018-2030 (USD MILLION)
TABLE 276. RUSSIA EXOSKELETON MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 277. RUSSIA EXOSKELETON MARKET SIZE, BY CORPORATE, 2018-2030 (USD MILLION)
TABLE 278. RUSSIA EXOSKELETON MARKET SIZE, BY END CONSUMERS, 2018-2030 (USD MILLION)
TABLE 279. RUSSIA EXOSKELETON MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 280. RUSSIA EXOSKELETON MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 281. RUSSIA EXOSKELETON MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 282. RUSSIA EXOSKELETON MARKET SIZE, BY COMPOSITES, 2018-2030 (USD MILLION)
TABLE 283. RUSSIA EXOSKELETON MARKET SIZE, BY STEEL & ALLOYS, 2018-2030 (USD MILLION)
TABLE 284. ITALY EXOSKELETON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 285. ITALY EXOSKELETON MARKET SIZE, BY FULL BODY EXOSKELETONS, 2018-2030 (USD MILLION)
TABLE 286. ITALY EXOSKELETON MARKET SIZE, BY LOWER BODY EXOSKELETONS, 2018-2030 (USD MILLION)
TABLE 287. ITALY EXOSKELETON MARKET SIZE, BY NON-POWERED LOWER BODY, 2018-2030 (USD MILLION)
TABLE 288. ITALY EXOSKELETON MARKET SIZE, BY POWERED LOWER BODY, 2018-2030 (USD MILLION)
TABLE 289. ITALY EXOSKELETON MARKET SIZE, BY UPPER BODY EXOSKELETONS, 2018-2030 (USD MILLION)
TABLE 290. ITALY EXOSKELETON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 291. ITALY EXOSKELETON MARKET SIZE, BY ACCESSIBILITY AIDS, 2018-2030 (USD MILLION)
TABLE 292. ITALY EXOSKELETON MARKET SIZE, BY HEALTHCARE, 2018-2030 (USD MILLION)
TABLE 293. ITALY EXOSKELETON MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
TABLE 294. ITALY EXOSKELETON MARKET SIZE, BY MILITARY & DEFENSE, 2018-2030 (USD MILLION)
TABLE 295. ITALY EXOSKELETON MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 296. ITALY EXOSKELETON MARKET SIZE, BY CORPORATE, 2018-2030 (USD MILLION)
TABLE 297. ITALY EXOSKELETON MARKET SIZE, BY END CONSUMERS, 2018-2030 (USD MILLION)
TABLE 298. ITALY EXOSKELETON MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 299. ITALY EXOSKELETON MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 300. ITALY EXOSKELETON MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 301. ITALY EXOSKELETON MARKET SIZE, BY COMPOSITES, 2018-2030 (USD MILLION)
TABLE 302. ITALY EXOSKELETON MARKET SIZE, BY STEEL & ALLOYS, 2018-2030 (USD MILLION)
TABLE 303. SPAIN EXOSKELETON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 304. SPAIN EXOSKELETON MARKET SIZE, BY FULL BODY EXOSKELETONS, 2018-2030 (USD MILLION)
TABLE 305. SPAIN EXOSKELETON MARKET SIZE, BY LOWER BODY EXOSKELETONS, 2018-2030 (USD MILLION)
TABLE 306. SPAIN EXOSKELETON MARKET SIZE, BY NON-POWERED LOWER BODY, 2018-2030 (USD MILLION)
TABLE 307. SPAIN EXOSKELETON MARKET SIZE, BY POWERED LOWER BODY, 2018-2030 (USD MILLION)
TABLE 308. SPAIN EXOSKELETON MARKET SIZE, BY UPPER BODY EXOSKELETONS, 2018-2030 (USD MILLION)
TABLE 309. SPAIN EXOSKELETON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 310. SPAIN EXOSKELETON MARKET SIZE, BY ACCESSIBILITY AIDS, 2018-2030 (USD MILLION)
TABLE 311. SPAIN EXOSKELETON MARKET SIZE, BY HEALTHCARE, 2018-2030 (USD MILLION)
TABLE 312. SPAIN EXOSKELETON MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
TABLE 313. SPAIN EXOSKELETON MARKET SIZE, BY MILITARY & DEFENSE, 2018-2030 (USD MILLION)
TABLE 314. SPAIN EXOSKELETON MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 315. SPAIN EXOSKELETON MARKET SIZE, BY CORPORATE, 2018-2030 (USD MILLION)
TABLE 316. SPAIN EXOSKELETON MARKET SIZE, BY END CONSUMERS, 2018-2030 (USD MILLION)
TABLE 317. SPAIN EXOSKELETON MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 318. SPAIN EXOSKELETON MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 319. SPAIN EXOSKELETON MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 320. SPAIN EXOSKELETON MARKET SIZE, BY COMPOSITES, 2018-2030 (USD MILLION)
TABLE 321. SPAIN EXOSKELETON MARKET SIZE, BY STEEL & ALLOYS, 2018-2030 (USD MILLION)
TABLE 322. UNITED ARAB EMIRATES EXOSKELETON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 323. UNITED ARAB EMIRATES EXOSKELETON MARKET SIZE, BY FULL BODY EXOSKELETONS, 2018-2030 (USD MILLION)
TABLE 324. UNITED ARAB EMIRATES EXOSKELETON MARKET SIZE, BY LOWER BODY EXOSKELETONS, 2018-2030 (USD MILLION)
TABLE 325. UNITED ARAB EMIRATES EXOSKELETON MARKET SIZE, BY NON-POWERED LOWER BODY, 2018-2030 (USD MILLION)
TABLE 326. UNITED ARAB EMIRATES EXOSKELETON MARKET SIZE, BY POWERED LOWER BODY, 2018-2030 (USD MILLION)
TABLE 327. UNITED ARAB EMIRATES EXOSKELETON MARKET SIZE, BY UPPER BODY EXOSKELETONS, 2018-2030 (USD MILLION)
TABLE 328. UNITED ARAB EMIRATES EXOSKELETON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 329. UNITED ARAB EMIRATES EXOSKELETON MARKET SIZE, BY ACCESSIBILITY AIDS, 2018-2030 (USD MILLION)
TABLE 330. UNITED ARAB EMIRATES EXOSKELETON MARKET SIZE, BY HEALTHCARE, 2018-2030 (USD MILLION)
TABLE 331. UNITED ARAB EMIRATES EXOSKELETON MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
TABLE 332. UNITED ARAB EMIRATES EXOSKELETON MARKET SIZE, BY MILITARY & DEFENSE, 2018-2030 (USD MILLION)
TABLE 333. UNITED ARAB EMIRATES EXOSKELETON MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 334. UNITED ARAB EMIRATES EXOSKELETON MARKET SIZE, BY CORPORATE, 2018-2030 (USD MILLION)
TABLE 335. UNITED ARAB EMIRATES EXOSKELETON MARKET SIZE, BY END CONSUMERS, 2018-2030 (USD MILLION)
TABLE 336. UNITED ARAB EMIRATES EXOSKELETON MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 337. UNITED ARAB EMIRATES EXOSKELETON MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 338. UNITED ARAB EMIRATES EXOSKELETON MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 339. UNITED ARAB EMIRATES EXOSKELETON MARKET SIZE, BY COMPOSITES, 2018-2030 (USD MILLION)
TABLE 340. UNITED ARAB EMIRATES EXOSKELETON MARKET SIZE, BY STEEL & ALLOYS, 2018-2030 (USD MILLION)
TABLE 341. SAUDI ARABIA EXOSKELETON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 342. SAUDI ARABIA EXOSKELETON MARKET SIZE, BY FULL BODY EXOSKELETONS, 2018-2030 (USD MILLION)
TABLE 343. SAUDI ARABIA EXOSKELETON MARKET SIZE, BY LOWER BODY EXOSKELETONS, 2018-2030 (USD MILLION)
TABLE 344. SAUDI ARABIA EXOSKELETON MARKET SIZE, BY NON-POWERED LOWER BODY, 2018-2030 (USD MILLION)
TABLE 345. SAUDI ARABIA EXOSKELETON MARKET SIZE, BY POWERED LOWER BODY, 2018-2030 (USD MILLION)
TABLE 346. SAUDI ARABIA EXOSKELETON MARKET SIZE, BY UPPER BODY EXOSKELETONS, 2018-2030 (USD MILLION)
TABLE 347. SAUDI ARABIA EXOSKELETON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 348. SAUDI ARABIA EXOSKELETON MARKET SIZE, BY ACCESSIBILITY AIDS, 2018-2030 (USD MILLION)
TABLE 349. SAUDI ARABIA EXOSKELETON MARKET SIZE, BY HEALTHCARE, 2018-2030 (USD MILLION)
TABLE 350. SAUDI ARABIA EXOSKELETON MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
TABLE 351. SAUDI ARABIA EXOSKELETON MARKET SIZE, BY MILITARY & DEFENSE, 2018-2030 (USD MILLION)
TABLE 352. SAUDI ARABIA EXOSKELETON MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 353. SAUDI ARABIA EXOSKELETON MARKET SIZE, BY CORPORATE, 2018-2030 (USD MILLION)
TABLE 354. SAUDI ARABIA EXOSKELETON MARKET SIZE, BY END CONSUMERS, 2018-2030 (USD MILLION)
TABLE 355. SAUDI ARABIA EXOSKELETON MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 356. SAUDI ARABIA EXOSKELETON MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 357. SAUDI ARABIA EXOSKELETON MARKET SIZE, BY MATERIAL TY

Companies Mentioned

The companies profiled in this Exoskeleton market report include:
  • ABLE Human Motion S.L.
  • B-Temia
  • Comau S.p.A.
  • CYBERDYNE INC.
  • Ekso Bionics Holdings, Inc.
  • German Bionic Systems GmbH
  • GOGOA MOBILITY ROBOTS, SL
  • HeroWear, LLC
  • Hocoma AG
  • Hyundai Motor Group
  • Laevo BV
  • Lifeward, Inc.
  • Lockheed Martin Corporation.
  • MAWASHI SCIENCE & TECHNOLOGY
  • Myomo Inc.
  • Ottobock SE
  • Panasonic Holdings Corporation
  • RB3D
  • Rex Bionics Ltd.
  • Robert Bosch GmbH
  • Shanghai Fourier Intelligence Co. Ltd.
  • Wandercraft

Methodology

Loading
LOADING...

Table Information